KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Inventory Average (2016 - 2022)

Historic Inventory Average for TherapeuticsMD (TXMD) over the last 9 years, with Q3 2022 value amounting to $6.4 million.

  • TherapeuticsMD's Inventory Average fell 1395.96% to $6.4 million in Q3 2022 from the same period last year, while for Sep 2022 it was $6.4 million, marking a year-over-year decrease of 1395.96%. This contributed to the annual value of $7.8 million for FY2021, which is 2134.97% down from last year.
  • Per TherapeuticsMD's latest filing, its Inventory Average stood at $6.4 million for Q3 2022, which was down 1395.96% from $7.6 million recorded in Q2 2022.
  • TherapeuticsMD's 5-year Inventory Average high stood at $13.2 million for Q1 2020, and its period low was $1.6 million during Q1 2018.
  • Over the past 5 years, TherapeuticsMD's median Inventory Average value was $7.5 million (recorded in 2021), while the average stood at $6.7 million.
  • In the last 5 years, TherapeuticsMD's Inventory Average soared by 32329.51% in 2019 and then tumbled by 4204.74% in 2021.
  • TherapeuticsMD's Inventory Average (Quarter) stood at $2.8 million in 2018, then skyrocketed by 296.63% to $11.2 million in 2019, then dropped by 19.95% to $9.0 million in 2020, then dropped by 16.41% to $7.5 million in 2021, then fell by 14.24% to $6.4 million in 2022.
  • Its Inventory Average was $6.4 million in Q3 2022, compared to $7.6 million in Q2 2022 and $8.3 million in Q1 2022.